Market Overview

Pluvia Securities Out With Long/Short Trade Idea, Bellicum Long and Bluebird Bio Short As Firm Says Bellicum Pipeline Beats/Obsoletes BLUE's 3 Lead Drug Candidates

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for BLUE

DateFirmActionFromTo
Dec 2017Maxim GroupDowngradesBuyHold
Dec 2017JefferiesUpgradesHoldBuy
Dec 2017Canaccord GenuityInitiates Coverage OnBuy

View More Analyst Ratings for BLUE
View the Latest Analyst Ratings

Posted-In: Analyst Color Long Ideas Short Ideas Analyst Ratings Trading Ideas

 

Related Articles (BLUE + BLCM)